Salman Otoukesh

459 total citations
24 papers, 116 citations indexed

About

Salman Otoukesh is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Salman Otoukesh has authored 24 papers receiving a total of 116 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 9 papers in Genetics and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Salman Otoukesh's work include Hematopoietic Stem Cell Transplantation (12 papers), Acute Myeloid Leukemia Research (7 papers) and Acute Lymphoblastic Leukemia research (6 papers). Salman Otoukesh is often cited by papers focused on Hematopoietic Stem Cell Transplantation (12 papers), Acute Myeloid Leukemia Research (7 papers) and Acute Lymphoblastic Leukemia research (6 papers). Salman Otoukesh collaborates with scholars based in United States, Switzerland and Iran. Salman Otoukesh's co-authors include Monzr M. Al Malki, Stephen J. Forman, Shahrzad Bazargan‐Hejazi, Dean Sherzai, Mohsen Bazargan, Idoroenyi Amanam, Amandeep Salhotra, Ryotaro Nakamura, Guido Marcucci and Anthony S. Stein and has published in prestigious journals such as Blood, International Journal of Molecular Sciences and American Journal of Tropical Medicine and Hygiene.

In The Last Decade

Salman Otoukesh

17 papers receiving 114 citations

Peers

Salman Otoukesh
Andrea Di Palma Italy
Colleen Timlin United States
Nieves Dorado Spain
Paibel Aguayo‐Hiraldo United States
Susan Flesch United States
Anna Nordlander Sweden
David Choi United States
Ashley Morris Engemann United States
Daniele Armiento Italy
Elisa Zucchetti Italy
Andrea Di Palma Italy
Salman Otoukesh
Citations per year, relative to Salman Otoukesh Salman Otoukesh (= 1×) peers Andrea Di Palma

Countries citing papers authored by Salman Otoukesh

Since Specialization
Citations

This map shows the geographic impact of Salman Otoukesh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salman Otoukesh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salman Otoukesh more than expected).

Fields of papers citing papers by Salman Otoukesh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salman Otoukesh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salman Otoukesh. The network helps show where Salman Otoukesh may publish in the future.

Co-authorship network of co-authors of Salman Otoukesh

This figure shows the co-authorship network connecting the top 25 collaborators of Salman Otoukesh. A scholar is included among the top collaborators of Salman Otoukesh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salman Otoukesh. Salman Otoukesh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Amanam, Idoroenyi, Salman Otoukesh, Vinod Pullarkat, et al.. (2025). Myelofibrosis-associated extramedullary hematopoiesis: Insights into hepatic, pulmonary, and thrombotic complications. Blood Reviews. 75. 101355–101355.
2.
Salhotra, Amandeep, Jamie R. Wagner, Dongyun Yang, et al.. (2025). First-in-human trial of allogeneic CD6-CAR tregs in patients with chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation. Blood. 146(Supplement 1). 276–276.
3.
Ngo, Dat, et al.. (2024). Hypomethylating Agents are Effective in Treatment for Relapsed Myelofibrosis After Allogeneic Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 30(11). 1091.e1–1091.e8. 1 indexed citations
4.
Otoukesh, Salman, et al.. (2024). Blinatumomab-induced macrophage activating syndrome (MAS) in adult with B-cell acute lymphoblastic leukemia (B-ALL). Annals of Hematology. 103(7). 2541–2543.
5.
Fei, Fei, Amar Jariwala, Sheeja T. Pullarkat, et al.. (2024). Genomic Landscape of Myelodysplastic/Myeloproliferative Neoplasms: A Multi-Central Study. International Journal of Molecular Sciences. 25(18). 10214–10214. 3 indexed citations
6.
7.
Epstein, David J., Salman Otoukesh, Zainab Shahid, & Sanjeet Dadwal. (2024). Infectious Disease Considerations in Chronic Graft-versus-Host Disease and Transplantation Survivors. Transplantation and Cellular Therapy. 30(9). S534–S547.
8.
Salhotra, Amandeep, Dongyun Yang, Sally Mokhtari, et al.. (2024). Phase 1 Trial Investigating the Safety and Tolerability of Leflunomide in Patients with Steroid-Dependent Chronic Graft-Versus-Host Disease (cGVHD) after Allogeneic Hematopoietic Cell Transplant (alloHCT). Transplantation and Cellular Therapy. 30(2). S282–S283. 1 indexed citations
9.
Aldoss, Ibrahim, Jianying Zhang, Joo Y. Song, et al.. (2024). Flotetuzumab as a salvage immunotherapy in advanced CD123-positive hematological malignancies, a phase 1 pilot study. Leukemia & lymphoma. 65(8). 1127–1135. 1 indexed citations
10.
Amanam, Idoroenyi, Salman Otoukesh, Monzr M. Al Malki, & Amandeep Salhotra. (2023). Chronic GVHD: review advances in prevention, novel endpoints, and targeted strategies. Hematology. 2023(1). 164–170. 8 indexed citations
11.
12.
Amanam, Idoroenyi, et al.. (2022). Chronic Myelomonocytic Leukemia (CMML): A systematic Review of Literature and Update. 6(1). 1 indexed citations
13.
Ciurea, Stefan O., Monzr M. Al Malki, Piyanuch Kongtim, et al.. (2021). Treatment of allosensitized patients receiving allogeneic transplantation. Blood Advances. 5(20). 4031–4043. 34 indexed citations
14.
Otoukesh, Salman, Hany Elmariah, Dongyun Yang, et al.. (2021). Cytokine Release Syndrome Following Peripheral Blood Stem Cell Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide. Transplantation and Cellular Therapy. 28(2). 111.e1–111.e8. 12 indexed citations
15.
Yao, Janny M., Dongyun Yang, Mary C. Clark, et al.. (2021). Tacrolimus initial steady state level in post-transplant cyclophosphamide-based GvHD prophylaxis regimens. Bone Marrow Transplantation. 57(2). 232–242. 3 indexed citations
16.
Ball, Brian, Shukaib Arslan, Paul Koller, et al.. (2021). Outcomes of Venetoclax and Hypomethylating Agents (HMA) in Adult Patients with KMT2A-Rearranged Leukemias. Blood. 138(Supplement 1). 3430–3430. 1 indexed citations
17.
Otoukesh, Salman, Jianying Zhang, Ryotaro Nakamura, et al.. (2020). The efficacy of venetoclax and hypomethylating agents in acute myeloid leukemia with extramedullary involvement. Leukemia & lymphoma. 61(8). 2020–2023. 11 indexed citations
18.
Otoukesh, Salman, et al.. (2012). Portal Hypertension Secondary to Isolated Liver Tuberculosis. American Journal of Tropical Medicine and Hygiene. 87(1). 162–164. 11 indexed citations
19.
Otoukesh, Salman, et al.. (2012). A retrospective study of demographic parameters and major health referrals among Afghan refugees in Iran. International Journal for Equity in Health. 11(1). 82–82. 23 indexed citations
20.
Otoukesh, Salman, et al.. (2009). SOLITARY FIBROUS TUMOR OF THE PLEURA: A CASE REPORT AND REVIEW OF THE LITERATURE. 8(3). 69–76.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrea Di Palma Breakdown of academic impact, for papers by Colleen Timlin Breakdown of academic impact, for papers by Nieves Dorado Breakdown of academic impact, for papers by Paibel Aguayo‐Hiraldo Breakdown of academic impact, for papers by Susan Flesch Breakdown of academic impact, for papers by Anna Nordlander Breakdown of academic impact, for papers by David Choi Breakdown of academic impact, for papers by Ashley Morris Engemann Breakdown of academic impact, for papers by Daniele Armiento Breakdown of academic impact, for papers by Elisa Zucchetti
Rankless by CCL
2026